Metastatic Cervical Cancer Completed Phase 2 Trials for Camrelizumab (DB14776)

Also known as: Metastatic Cervical Cancers / Cervical Cancer Metastatic

IndicationStatusPhase
DBCOND0036674 (Metastatic Cervical Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03816553SHR-1210 in Combination With Apatinib in Patients With Metastatic, Persistent, or Recurrent Cervical CancerTreatment